Mutations in the DBP-deficiency protein HSD17B4 cause ovarian dysgenesis, hearing loss, and ataxia of Perrault Syndrome - PubMed (original) (raw)
Mutations in the DBP-deficiency protein HSD17B4 cause ovarian dysgenesis, hearing loss, and ataxia of Perrault Syndrome
Sarah B Pierce et al. Am J Hum Genet. 2010.
Abstract
Perrault syndrome is a recessive disorder characterized by ovarian dysgenesis in females, sensorineural deafness in both males and females, and in some patients, neurological manifestations. No genes for Perrault syndrome have heretofore been identified. A small family of mixed European ancestry includes two sisters with well-characterized Perrault syndrome. Whole-exome sequencing of genomic DNA from one of these sisters revealed exactly one gene with two rare functional variants: HSD17B4, which encodes 17beta-hydroxysteroid dehydrogenase type 4 (HSD17B4), also known as D-bifunctional protein (DBP). HSD17B4/DBP is a multifunctional peroxisomal enzyme involved in fatty acid beta-oxidation and steroid metabolism. Both sisters are compound heterozygotes for HSD17B4 c.650A>G (p.Y217C) (maternal allele) and HSB17B4 c.1704T>A (p.Y568X) (paternal allele). The missense mutation is predicted by structural analysis to destabilize the HSD17B4 dehydrogenase domain. The nonsense mutation leads to very low levels of HSD17B4 transcript. Expression of mutant HSD17B4 protein in a compound heterozygote was severely reduced. Mutations in HSD17B4 are known to cause DBP deficiency, an autosomal-recessive disorder of peroxisomal fatty acid beta-oxidation that is generally fatal within the first two years of life. No females with DBP deficiency surviving past puberty have been reported, and ovarian dysgenesis has not previously been associated with this illness. Six other families with Perrault syndrome have wild-type sequences of HSD17B4. These results indicate that Perrault syndrome and DBP deficiency overlap clinically; that Perrault syndrome is genetically heterogeneous; that DBP deficiency may be underdiagnosed; and that whole-exome sequencing can reveal critical genes in small, nonconsanguineous families.
Figures
Figure 1
Coumpound Heterozygosity for HSD17B4 Mutations in Family 4 (A) Pedigree of Perrault syndrome family 4. (B) Validation by Sanger sequencing of HSD17B4 mutations identified in individual 4-01 by whole-exome sequencing. Genomic DNA was sequenced after amplification with primers flanking exon 9 (5′- TGGAAAGGTGTGTCTGATAC-3′, 5′- CAAATGTAGAACTAAGTAAAAAC-3′) and exon 20 (5′- TTGAAAGACAAAGAATTGGC-3′, 5′-TGAAAACACCAGACAAGCTG-3′). Arrows indicate heterozygosity for chr5:118,824,914A>G, HSD17B4 c.650A>G (p.Y217C), in the upper panel, and for chr5:118,862,851T>A, HSB17B4 c.1704T>A (p.Y568X), in the lower panel. (C) Schematic of the HSD17B4 protein. (D) Diagram of the four steps of peroxisomal β-oxidation (left) and the enzymes by which they are catalyzed (right), using oxidation of very long chain fatty acids (VLCFA) as an example. (E) Protein sequence alignment of HSD17B4 orthologs, showing the region surrounding the mutated Y217 (indicated in red). The project was approved by the Human Subjects Division of the University of Washington, and informed consent was obtained from all of the subjects.
Figure 2
Expression of HSD17B4 Mutant Transcripts and Protein (A) Expression of the two mutant transcripts of HSD17B4. Gene-specific cDNA for HSD17B4 was prepared from lymphoblast RNA of patient 4-02 and an unrelated control. cDNA was generated from total RNA with a primer located in exon 23 (5′- CCAGAACCACTTTTCAGGTCAATAGTCCAC-3′), amplified with primer pairs spanning exons 7–12 (5′-GGGTTCATTCCAAGTGACAC-3′, 5′-TCCTGATGTTGCTGTAGACG-3′) and exons 17–22, (5′- GCCATACCTAATAGACCTCC-3′, 5′- CAGCATTTACTTTCTTCACC-3′), and Sanger sequenced. The upper panels indicate sequence from patient 4-02, whose genomic DNA is heterozygous at nucleotide positions c.650, c.1687 (rs11205), and c.1704. The cDNA sequence harboring the GGT haplotype, which carries the missense allele G at c.650, the G allele at c.1687, and the wild-type allele T at c.1704 is more highly expressed than the sequence harboring the AAA haplotype, which carries the wild-type allele A at c.650, the A allele at c.1687, and the nonsense allele A at c.1704. The lower panels indicate sequence from an unrelated control, who is heterozygous at c.1687 and wild-type at c.650 and c.1704. The two alleles of the SNP at c.1687 appear equally expressed in the lymphoblast cDNA of the control. (B) Lymphoblast cell lysates (50 μg) of patients (4-02 and 4-03) and controls (C1–C4) and Huh7 lysates (10 μg) were analyzed by immunoblotting using primary antibodies rabbit anti-HSD17B4 (Sigma) and mouse anti-β-actin (Sigma) and IRDye-conjugated secondary antibodies (LI-COR Biosciences). Full-length HSD17B4 (79 kD) and the processed dehydrogenase domain (35 kD) are indicated.
Figure 3
Structure of the HSD17B4 Dehydrogenase Domain A ribbon representation of the HSD17B4 dehydrogenase domain in complex with NAD (PDB
1GZ6
), showing the region surrounding the mutated residue Y217. The A and B chains of the homodimer are colored green and blue, respectively. NAD is represented as sticks within the binding site. As explained in the text, substitution of cysteine for tyrosine at position 217 is predicted to abrogate the cation-π orbital interaction of Y217 and R258 and thus the critical charged interaction of R258 with D303, leading to destabilization of the dehydrogenase domain and loss of specific activity of the enzyme.
Similar articles
- Specific combination of compound heterozygous mutations in 17β-hydroxysteroid dehydrogenase type 4 (HSD17B4) defines a new subtype of D-bifunctional protein deficiency.
McMillan HJ, Worthylake T, Schwartzentruber J, Gottlieb CC, Lawrence SE, Mackenzie A, Beaulieu CL, Mooyer PA; FORGE Canada Consortium; Wanders RJ, Majewski J, Bulman DE, Geraghty MT, Ferdinandusse S, Boycott KM. McMillan HJ, et al. Orphanet J Rare Dis. 2012 Nov 22;7:90. doi: 10.1186/1750-1172-7-90. Orphanet J Rare Dis. 2012. PMID: 23181892 Free PMC article. - A homozygous missense variant in HSD17B4 identified in a consanguineous Chinese Han family with type II Perrault syndrome.
Chen K, Yang K, Luo SS, Chen C, Wang Y, Wang YX, Li DK, Yang YJ, Tang YL, Liu FT, Wang J, Wu JJ, Sun YM. Chen K, et al. BMC Med Genet. 2017 Aug 23;18(1):91. doi: 10.1186/s12881-017-0453-0. BMC Med Genet. 2017. PMID: 28830375 Free PMC article. - Next generation sequencing with copy number variant detection expands the phenotypic spectrum of HSD17B4-deficiency.
Lieber DS, Hershman SG, Slate NG, Calvo SE, Sims KB, Schmahmann JD, Mootha VK. Lieber DS, et al. BMC Med Genet. 2014 Mar 6;15:30. doi: 10.1186/1471-2350-15-30. BMC Med Genet. 2014. PMID: 24602372 Free PMC article. - An Application of NGS for Molecular Investigations in Perrault Syndrome: Study of 14 Families and Review of the Literature.
Lerat J, Jonard L, Loundon N, Christin-Maitre S, Lacombe D, Goizet C, Rouzier C, Van Maldergem L, Gherbi S, Garabedian EN, Bonnefont JP, Touraine P, Mosnier I, Munnich A, Denoyelle F, Marlin S. Lerat J, et al. Hum Mutat. 2016 Dec;37(12):1354-1362. doi: 10.1002/humu.23120. Epub 2016 Oct 7. Hum Mutat. 2016. PMID: 27650058 Review.
Cited by
- HSD17B4 mutation: an unusual cause of cerebellar ataxia.
Mehta S, Singh J, Sharma A, Kumar M, Lal V. Mehta S, et al. Neurol Sci. 2024 Oct 9. doi: 10.1007/s10072-024-07779-z. Online ahead of print. Neurol Sci. 2024. PMID: 39379670 No abstract available. - Premature ovarian insufficiency.
Touraine P, Chabbert-Buffet N, Plu-Bureau G, Duranteau L, Sinclair AH, Tucker EJ. Touraine P, et al. Nat Rev Dis Primers. 2024 Sep 12;10(1):63. doi: 10.1038/s41572-024-00547-5. Nat Rev Dis Primers. 2024. PMID: 39266563 Review. - Discovering predisposing genes for hereditary breast cancer using deep learning.
Passi G, Lieberman S, Zahdeh F, Murik O, Renbaum P, Beeri R, Linial M, May D, Levy-Lahad E, Schneidman-Duhovny D. Passi G, et al. Brief Bioinform. 2024 May 23;25(4):bbae346. doi: 10.1093/bib/bbae346. Brief Bioinform. 2024. PMID: 39038933 Free PMC article. - Diagnosis and management of non-CAH 46,XX disorders/differences in sex development.
Yavas Abalı Z, Guran T. Yavas Abalı Z, et al. Front Endocrinol (Lausanne). 2024 May 15;15:1354759. doi: 10.3389/fendo.2024.1354759. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38812815 Free PMC article. Review. - D-Bifunctional Protein Deficiency Diagnosis-A Challenge in Low Resource Settings: Case Report and Review of the Literature.
Ognean ML, Mutică IB, Vișa GA, Șofariu CR, Matei C, Neamțu B, Cucerea M, Galiș R, Cocișiu GA, Mătăcuță-Bogdan IO. Ognean ML, et al. Int J Mol Sci. 2024 Apr 30;25(9):4924. doi: 10.3390/ijms25094924. Int J Mol Sci. 2024. PMID: 38732138 Free PMC article. Review.
References
- Perrault M., Klotz B., Housset E. Deux cas de syndrome de Turner avec surdi-mudité dans une même fratrie. [Two cases of Turner syndrome with deaf-mutism in two sisters] Bull. Mem. Soc. Med. Hop. Paris. 1951;67:79–84. - PubMed
- Nishi Y., Hamamoto K., Kajiyama M., Kawamura I. The Perrault syndrome: clinical report and review. Am. J. Med. Genet. 1988;31:623–629. - PubMed
- Gottschalk M.E., Coker S.B., Fox L.A. Neurologic anomalies of Perrault syndrome. Am. J. Med. Genet. 1996;65:274–276. - PubMed
- McCarthy D.J., Opitz J.M. Perrault syndrome in sisters. Am. J. Med. Genet. 1985;22:629–631. - PubMed
- Fiumara A., Sorge G., Toscano A., Parano E., Pavone L., Opitz J.M. Perrault syndrome: evidence for progressive nervous system involvement. Am. J. Med. Genet. A. 2004;128A:246–249. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous